CRISM Therapeutics Corporation
CRTX.L
London Stock Exchange10.00
GBp
-0.75
- -
Total Valuation
CRISM Therapeutics Corporation carries a market capitalization of 3.85M, placing it among publicly traded companies globally.
| Market Cap | 3.85M |
| Enterprise Value | N/A |
Stock Price Statistics
CRISM Therapeutics Corporation's stock has declined approximately -11.11111% over the past 52 weeks. The 50-day moving average sits at 11.17, while the 200-day moving average is 11.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.11111% |
| 50-Day Moving Average | 11.17 |
| 200-Day Moving Average | 11.50 |
| Average Volume (20 Days) | N/A |
Stock Splits
CRISM Therapeutics Corporation's most recent stock split took place on May 31, 2024 with a 160:1 split ratio.
| Last Split Date | 5/31/2024 |
| Split Ratio | 160:1 |